In the recently concluded finals of the 10th Suzhou Women’s Entrepreneurship and Innovation Competition, titled ” Create a Smart Future by Winning in Suzhou,” HymonBio stood out from many outstanding scientific and technological projects with its project “AI Empowered Pan-Cancer Early Screening: Industrial Breakthrough in Accurate ctDNA Methylation Detection,” and successfully won the second prize of the competition with an outstanding score of second place!
This time, HymonBio’s project integrates the latest artificial intelligence with biotechnology, successfully developing the world’s first pan-cancer early screening product on the PCR. With just 5 mL of blood, it can screen for 28 common cancers, without the need for fasting and testing can be done on-demand, greatly improving accessibility and inclusiveness of national screening.
HymonBio will take this competition as an opportunity to continue to deepen technological research and development, contribute scientific and technological strength to the implementation of a healthy China, strive to allow more innovative results for public benefit, and work tirelessly to achieve health goal of “early detection, early diagnosis, and early treatment.”
Post time: Aug-27-2025


